関連する実験動画
Updated: Jul 14, 2026

13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
遺伝性血色腫のスクリーニングは,家族内および家族外で実施されます
C Anne McCune1, David Ravine, Mark Worwood
1Department of Haematology, University of Wales College of Medicine, Heath Park, CF14 4XN, Cardiff, UK. McCuneCA@cf.ac.uk
Lancet (London, England)
|December 12, 2003
まとめ
献血者における遺伝性血色腫症 (HH) の遺伝子スクリーニングは,家族による検査の利用率が低い. HHの臨床診断は,より高い相対的な検査率をもたらし,人口のスクリーニングの有効性に影響を与えます.
科学分野:
- 医学遺伝学 医学遺伝学
- 公衆衛生は公衆衛生である.
- クリニカル・メディシン 臨床医学
背景:
- 遺伝性血色腫症 (HH) の集団スクリーニングは,家族を特定することによって費用対効果を目的としています.
- C282Y変異は,HHの主要な遺伝的原因です.
研究 の 目的:
- 2つのインデックスケースグループから1級親族の間で遺伝子スクリーニングの利用率を比較するために:C282Y変異を有する献血者および臨床的に診断されたHH患者.
- ファミリースクリーニングの有効性に対する確定方法の影響を評価する.
主な方法:
- 1級親族におけるスクリーニングの利用率の遡及的分析.
- C282Y陽性献血者の親族と臨床的に診断されたHH患者の比較.
- 検査されていない親戚の診断されていない鉄過負荷の評価.
主要な成果:
- 献血者の親族の24% (40/165) だけが遺伝子検査を受けた.
- 臨床的に診断されたHH患者の親族では,検査の利用率が有意に高かった (53%).
- 検査されていない親戚の相当な割合は,診断されていない鉄過負荷を患っていた.
結論:
- 現在,献血者の確認に基づいたHHの集団スクリーニング戦略は,家族を巻き込むのに限られた成功を収めている.
- HHの臨床的確認は,家族のスクリーニング参加を向上させます.
- 低摂取は,人口ベースのHHスクリーニングプログラムの全体的な効果を損なう.
関連する概念動画
Pedigree Analysis
Overview
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

